|  | 
|  | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhasePreclinical | 
| First Approval Ctry. / Loc.- | 
| First Approval Date20 Jan 1800 | 
100 Clinical Results associated with CD16a x c-Kit x CD47
100 Translational Medicine associated with CD16a x c-Kit x CD47
0  Patents (Medical) associated with CD16a x c-Kit x CD47